If you liked this article you might like

Impax (IPXL) Stock Plummets on Weak Q2 Results, Guidance
Changing Landscape for Generic-Drug Makers Creates Opportunities
Teva Inches Closer to Completion of Allergan Generics Deal
Impax Laboratories (IPXL) Marked As A Dead Cat Bounce Stock